S&P 500   4,133.53 (-0.73%)
DOW   34,072.88 (-0.25%)
QQQ   304.58 (-1.71%)
AAPL   151.32 (-2.15%)
MSFT   268.74 (+0.44%)
META   185.16 (-3.37%)
GOOGL   99.08 (-7.95%)
AMZN   99.85 (-2.21%)
TSLA   198.62 (+0.92%)
NVDA   224.16 (+1.10%)
NIO   10.65 (-2.47%)
BABA   105.52 (+0.02%)
AMD   85.47 (-0.51%)
T   19.13 (-0.62%)
F   13.47 (+0.15%)
MU   60.60 (-2.46%)
CGC   2.76 (-2.13%)
GE   82.00 (-0.13%)
DIS   111.29 (-0.30%)
AMC   5.73 (-7.28%)
PFE   43.88 (+0.67%)
PYPL   80.16 (-3.69%)
NFLX   360.86 (-0.58%)
S&P 500   4,133.53 (-0.73%)
DOW   34,072.88 (-0.25%)
QQQ   304.58 (-1.71%)
AAPL   151.32 (-2.15%)
MSFT   268.74 (+0.44%)
META   185.16 (-3.37%)
GOOGL   99.08 (-7.95%)
AMZN   99.85 (-2.21%)
TSLA   198.62 (+0.92%)
NVDA   224.16 (+1.10%)
NIO   10.65 (-2.47%)
BABA   105.52 (+0.02%)
AMD   85.47 (-0.51%)
T   19.13 (-0.62%)
F   13.47 (+0.15%)
MU   60.60 (-2.46%)
CGC   2.76 (-2.13%)
GE   82.00 (-0.13%)
DIS   111.29 (-0.30%)
AMC   5.73 (-7.28%)
PFE   43.88 (+0.67%)
PYPL   80.16 (-3.69%)
NFLX   360.86 (-0.58%)
S&P 500   4,133.53 (-0.73%)
DOW   34,072.88 (-0.25%)
QQQ   304.58 (-1.71%)
AAPL   151.32 (-2.15%)
MSFT   268.74 (+0.44%)
META   185.16 (-3.37%)
GOOGL   99.08 (-7.95%)
AMZN   99.85 (-2.21%)
TSLA   198.62 (+0.92%)
NVDA   224.16 (+1.10%)
NIO   10.65 (-2.47%)
BABA   105.52 (+0.02%)
AMD   85.47 (-0.51%)
T   19.13 (-0.62%)
F   13.47 (+0.15%)
MU   60.60 (-2.46%)
CGC   2.76 (-2.13%)
GE   82.00 (-0.13%)
DIS   111.29 (-0.30%)
AMC   5.73 (-7.28%)
PFE   43.88 (+0.67%)
PYPL   80.16 (-3.69%)
NFLX   360.86 (-0.58%)
S&P 500   4,133.53 (-0.73%)
DOW   34,072.88 (-0.25%)
QQQ   304.58 (-1.71%)
AAPL   151.32 (-2.15%)
MSFT   268.74 (+0.44%)
META   185.16 (-3.37%)
GOOGL   99.08 (-7.95%)
AMZN   99.85 (-2.21%)
TSLA   198.62 (+0.92%)
NVDA   224.16 (+1.10%)
NIO   10.65 (-2.47%)
BABA   105.52 (+0.02%)
AMD   85.47 (-0.51%)
T   19.13 (-0.62%)
F   13.47 (+0.15%)
MU   60.60 (-2.46%)
CGC   2.76 (-2.13%)
GE   82.00 (-0.13%)
DIS   111.29 (-0.30%)
AMC   5.73 (-7.28%)
PFE   43.88 (+0.67%)
PYPL   80.16 (-3.69%)
NFLX   360.86 (-0.58%)
TSE:VBV

VBI Vaccines - VBV Stock Forecast, Price & News

Add
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1,300 shs
Average Volume
3,637 shs
Market Capitalization
C$308.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VBV stock logo

About VBI Vaccines (TSE:VBV) Stock

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines that closely mimic the target virus. It is also developing congenital cytomegalovirus vaccine candidate for infectious disease; and therapeutic glioblastoma multiforme vaccine candidate for immuno-oncology. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts. VBI Vaccines Inc. is a subsidiary of FDS Pharma ASS.

Receive VBV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter.

VBV Stock News Headlines

The Humble Mineral at the Heart of the EV Revolution (Not Lithium)
You may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite – more than lithium, copper or aluminum!
The Humble Mineral at the Heart of the EV Revolution (Not Lithium)
You may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite – more than lithium, copper or aluminum!
VBI Vaccines Inc. (VBV.TO)
See More Headlines
Receive VBV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$3.36 million
Book Value
C$1.01 per share

Miscellaneous

Free Float
N/A
Market Cap
C$308.86 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Jeff R. Baxter (Age 57)
    CEO, Pres & Director
  • Dr. David Evander Anderson Ph.D. (Age 48)
    Chief Scientific Officer
  • Ms. Athena Kartsaklis (Age 53)
    Sr. VP of Fin., Principal Financial & Accounting Officer, Chief Compliance Officer
  • Ms. Nell Beattie (Age 30)
    Chief Bus. Officer
  • Dr. Francisco Diaz-Mitoma M.D. (Age 63)
    Ph.D., Chief Medical Officer













VBV Stock - Frequently Asked Questions

What other stocks do shareholders of VBI Vaccines own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VBI Vaccines investors own include Teladoc Health (TDOC), PhaseBio Pharmaceuticals (PHAS), Amarin (AMRN), Adverum Biotechnologies (ADVM), Assertio (ASRT), Activision Blizzard (ATVI), Axsome Therapeutics (AXSM), Boeing (BA), Beyond Meat (BYND) and Cardlytics (CDLX).

What is VBI Vaccines' stock symbol?

VBI Vaccines trades on the Toronto Stock Exchange (TSX) under the ticker symbol "VBV."

How do I buy shares of VBI Vaccines?

Shares of VBV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

How much money does VBI Vaccines make?

VBI Vaccines (TSE:VBV) has a market capitalization of C$0.00 and generates C$3.36 million in revenue each year.

How can I contact VBI Vaccines?

VBI Vaccines' mailing address is 222 3rd St Ste 2241, CAMBRIDGE, MA 02142-1259, United States. The official website for the company is www.vbivaccines.com. The company can be reached via phone at +1-617-8303031.

This page (TSE:VBV) was last updated on 2/8/2023 by MarketBeat.com Staff